Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second quarter ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Thursday before the bell. Here’s what ...

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

Eli Lilly (LLY) reports Q2 earnings on Aug 7, with booming diabetes and weight-loss drug sales driving strong growth.

Eli Lilly offers an annual dividend yield of 0.78%. So, how can investors exploit its dividend yield to pocket a regular $500 ...

Eli Lilly & Company (NYSE:LLY) is one of the top 10 medical AI companies to buy according to analysts. On July 29, the ...

The tariffs are Trump’s way of getting drug companies to move more of their operations to the U.S. at a time when domestic ...

Novo Nordisk (NVO) said Wednesday it will cut costs as it faces increasing competition from Eli Lilly (LLY) and generic ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

He projects LLY’s GLP-1 drug class to deliver revenue of $23 billion and $34 billion in 2025 and 2027, respectively, up from $8 billion in 2022, and then reach $50 billion in 2030.Wall Street ...